Cite

HARVARD Citation

    Barrière, J. et al. (2022). Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article. European journal of cancer. pp. 182-193. [Online]. 
  
Back to record